Experimental section

Reagents and apparatus:
Prostate specific antigen (PSA) from human semen was obtained from SigmaAldrich. Tetrachloroauric(III) acid trihydrate, sodium citrate, adenine, guanine, thymine, cytosine and 3-methyl-3H-purin-6-amine were obtained from Beijing InnoChem Science & Technology Co., Ltd. SsDNA (aptamer of PSA) with the following sequence: CGT CGT ATT AAA GCT CGC CAT CAA ATA GCT TT and phosphate buffered saline (PBS) buffer (10 mM, 1×) were obtained from Sangon Biotech (Shanghai) Co., Ltd. Human serum albumin (HSA), immunoglobulin G (IgG), transferrin (TF), and fetal bovine serum (FBA) were provided by Beijing Solarbio Science & Technology Co., Ltd. OliGreen ssDNA quantitation kit was purchased from Beijing Fanbo Biochemicals Co., Ltd. Enzyme linked immunosorbent assay (ELISA) kit for human total PSA was from Abcam Trading (Shanghai) Co., Ltd. Ultrapure water (over 18 M·cm) from a Milli-Q reference system (Millipore) was used throughout.
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) was performed on a Bruker Microflex time-of-flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with a 355 nm and 2 kHz solid state Nd:YAG Smart Beam laser. The mass spectrum was summed up by 200 shots at a laser repetition rate of 1000 Hz and analyzed by flexAnalysis (Bruker Daltonics, Germany). The mass spectra were typically recorded at an accelerating voltage of 19 kV and a reflection voltage of 20 kV with the laser pulse energy of 40 μJ. The fluorescence spectra were measured on microplate reader (Molecular Devices SpectraMax i3). Absorption spectra were made in 1 cm quartz cells with a TU-1900 spectrophotometer (Beijing, China). Transmission electron microscopy (TEM) was recorded on a Hitachi HT7700 transmission electron microscope at 100 kV. X-ray photoelectron spectroscopy (XPS) analysis was conducted by an ESCALAB 250XI X-ray photoelectron spectrometer (Thermo, USA).
Synthesis and characterization of gold nanoparticle
13-nm Au nanoparticles (AuNPs) were synthesized according to previous reports. [1, 2] Briefly, 50 mL of 1 mM HAuCl 4 was boiling with vigorous stirring, then 5 mL of 38.8 mM sodium citrate was rapidly added to the above solution and kept boiling for another 10 min to get a wine-red solution, then stopped heating and cooled to room temperature. The AuNPs filtered through a 0.45-µm membrane filter was characterized by UV/Vis spectrometry and transmission electron microscopy (TEM).
5-nm Au nanoparticles (AuNPs) were synthesized according to previous report. [3] Briefly, 10 mL of 1 mM HAuCl 4 was mixed with 1 mL of 38.8 mM trisodium citrate and vigorously stirred for 15 min. The mixture of 0.4 μg NaBH 4 and 0.4 mL trisodium citrate (38.8 mM) was slowly added to the precursor solution and stirred for 2 h.
30-nm Au nanoparticles (AuNPs) were synthesized according to previous report. [4] Briefly, 50 mL of 0.014% HAuCl 4 ·4H 2 O was boiling, and then 8 mL of 1% trisodium citrate was added to the boiling HAuCl 4 . The solution was kept boiling for 15 min and then cooled to room temperature under stirring.
Optimization of ssDNA binding to gold nanoparticles
To optimize the reaction conditions of pH and salt concentration, AuNPs solutions (1.3 nM, 200 μL) mixed with 1 μM 50 μL ssDNA in sodium phosphate (pH 3.0, 5.0 S4 and 7.4, 10 mM) or ultrapure water were co-incubated overnight. After two centrifugations (12000 rpm) and washing cycles, the concentration of the free ssDNA was determined by adding OliGreen (ssDNA labeling reagent, Molecular Probe,) and then measured the fluorescence with λ ex/em = 480/520 nm.
To optimize the size of AuNPs, different size of AuNPs (5, 13 and 30 nm) was incubated with ssDNA (final concentration 0.1 μM) overnight. Following the above steps, the concentration of the free ssDNA was measured to test the ability of loading ssDNA on different size of AuNPs.
To optimize the ratio of ssDNA and AuNPs, AuNPs solutions (1.3 nM, 200 μL) mixed with 1 μM ssDNA (10, 50, 100 and 150 μL) in pH 3.0 sodium phosphate were coincubated overnight. Following the above steps, the loading quantity and efficiency were measured.
To test the influence of positively charged species and , Na + , K + , Mg 2+ , tyrosine and cysteine with concentration of 0.1 mM were added into the Apt PSA /AuNPs solution. After incubating overnight, the influence of positively charged species was tested by measuring the unattached ssDNA in the supernatant.
Compare the binding affinity of ssDNA-AuNPs and ssDNA-target
AuNPs solutions (1.3 nM, 200 μL) were mixed with ssDNA (1 μM, 50 μL) in sodium phosphate (pH 3.0, 10 mM) and incubated overnight. The mixtures were centrifuged and washed twice, and then the solution was adjusted to 200 uL and separated into two parts. One part was dried in a vacuum. Prostate specific antigen with the final concentration of 40 ng/mL was added into the other part and incubated at room temperature for 1 h. With two centrifugation and washing cycles, the mixtures were also dried in a vacuum. AuNPs solutions in sodium phosphate (pH 3.0, 10 mM) were centrifuged and washed twice, then dried in a vacuum. The powders of AuNPs, AuNPsssDNA and AuNPs-ssDNA interacted with PSA, respectively were characterized using X-ray photoelectron spectroscopy (XPS). The intensity of the P 2p peak is dependent on surface coverage of ssDNA on AuNPs. The solutions of AuNPs, AuNPs-ssDNA and AuNPs-ssDNA interacted with PSA, respectively were recorded by absorption spectra. The red shift indicated the level of aggregation of AuNPs.
Albumin and tamm-horsfall protein (1 mg/mL) were added into the Apt PSA /AuNPs solution and incubated at room temperature for 1 hour. With two centrifugation and washing cycles, the mixtures were separated into two parts. One part was dried in a vacuum and characterized via XPS. The other part was recorded by absorption spectra.
Competitive binding of tag and ssDNA to gold nanoparticles
To an AuNPs suspension (200 µL, 1.3 nM), aptamers (50 μL, 1 μM) and 10 μL, 1 μM each tag (adenine, guanine, thymine, cytosine) were added and incubated overnight. The solution was centrifuged for 10 min at 12000 rpm with being washed by ultrapure water, then prostate specific antigen with the final concentration of 3 ng/mL was added and incubated at room temperature for 1 h. The solution was centrifuged for 10 min at 12000 rpm and washed three times with ultrapure water. The precipitate was resuspended to 20 µL water.
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Control experiment: all steps was the same as above operation, but without added PSA.
In MALDI-TOF MS analysis, 1 µL of the above suspension was premixed with 1 μL matrix (CCA) in a centrifuge tube, and then 1 μL of the resulting mixture was pipetted on the MALDI target plate and air-dried for further MS analysis.
The detection of PSA antigen using MALDI-TOF MS
To an AuNPs suspension (200 µL, 1.3 nM), PSA aptamers (50 μL, 1 μM) and adenine tag (10 μL, 1 μM) were added and incubated overnight. The solution was centrifuged for 10 min at 12000 rpm with washes using ultrapure water, then prostate specific antigen with the final concentration of 0.06, 0.3, 0.6, 3 and 6 ng/mL was added and incubated at room temperature for 1 h. The solution was centrifuged for 10 min at 12000 rpm and washed three times with ultrapure water. The precipitate was resuspended to 20 µL water. In MALDI-TOF MS analysis, 1 µL of the above suspension was premixed with 1 μL, 3-Methyladenine (IS, 0.1 μM) in a centrifuge tube, and then 1 μL of the resulting mixture was added into 1 μL matrix (CCA). Finally, 1 μL of the above mixture was pipetted on the MALDI target plate and air-dried for further MS analysis.
The PSA in healthy urine was removed by a 3 KD Ultra Centrifugal Filter (Merck Millipore, Germany), and the PSA standard was added into the above urine and the dilute urine with the concentration of 20 ng/mL. To aptamer-AuNPs solution, PSA in above two urines were added and incubated for 1 h, then subjected to the proposed method followed by MALDI-MS determination.
The specificity testing
To an AuNPs suspension (200 µL, 1.3 nM), PSA aptamers (50 μL, 1 μM) and adenine tag (10 μL, 1 μM) were added and incubated overnight. The solution was centrifuged for 10 min at 12000 rpm with washes using ultrapure water, then human serum albumin (HSA), immunoglobulin G (IgG), transferrin (TF), fetal bovine serum (FBA) with final concentration of 6 ng/mL and the mixture of PSA (0.6 ng/mL final concentration) with FBA was added and incubated at room temperature for 1 h respectively. The solution was centrifuged for 10 min at 12000 rpm and washed three times with ultrapure water. The precipitate was resuspended to 20 µL water. In MALDI-TOF MS analysis, 1 µL of the above suspension mixed with matrix was deposited onto the sampling plate and allowed to dry in air.
Tamm-horsfall protein (T-H protein) as the most abundant protein in urine was also selected to test the specificity of our approach. The mixture of T-H protein (the final concentration of 1 and 10 mg/mL) and PSA (3 ng/mL) were incubated with Apt PSA /AuNPs at room temperature for 1 h, respectively. PSA was mixed with Apt PSA /AuNPs as control experiment. then subjected to the proposed method followed by MALDI-MS determination.
Urine sample analysis
Fresh human urine of healthy people and patient was obtained from the Peking University People's Hospital (Beijing, China) according to the rules of the local ethical committee. Recovery experiments were conducted by spiking low, middle and high S6 concentrations (0.8, 8, 50 ng/mL) of PSA targets into healthy people's urine and then subjected to the proposed method followed by MALDI-MS determination. Clinical sample assays were performed by incubating one urine sample of healthy person and four urine samples from patients with aptamer-AuNPs mixture with adenine tags, and then followed the above approach. Serum sample analysis Serum tests were conducted by spiking various concentrations (3, 6, 15, 30 and 60 ng/mL) of PSA targets into healthy people's serum and then subjected to the proposed method followed by MALDI-MS determination.
The colorimetric assay
AuNPs solutions (1.3 nM, 200 μL) were mixed with ssDNA (0.1 μM, 100 μL) and PSA (8 ng/mL) solution with the final concentration of 0.06, 0.3, 0.6, 3 and 6 ng/mL for 30 min. Then NaCl solution (10 µL, 30 mM) was added to the mixtures, followed by AuNPs absorption monitoring using the UV/Vis spectrometry. [a] the mean ± deviation of three separate measurements
